Policymakers are enthusiastic about supporting domestic manufacturing of drugs and medical devices. Health care companies want to make sure they get their share of that support.
A problematic Emergent vaccine plant in Maryland still lacks approval, even after FDA declared some doses produced there are safe to use.
India is experiencing a surge in COVID-19 cases. The U.S. is sending supplies to help overwhelmed hospitals and speed up vaccine manufacturing.
After problems with the Johnson & Johnson and AstraZeneca vaccines, Europe plots a new course. Also, Johnson & Johnson leaders are optimistic about vaccine despite setbacks.
J&J’s shot makes up a small portion of the vaccine campaign in the U.S., so the impact should be small.
Armed with more data and real-world examples, some public health officials are renewing their calls to delay second doses
President Joe Biden’s infrastructure plan is light on details, but it could affect the health care supply chain.
The pandemic slashed ride volumes for medical transportation providers that brought patients to appointments. Now, some want to bring drugs and supplies to patients.
Companies that are normally competitors are making deals to share technology and manufacturing capacity to produce enough COVID-19 vaccines.
The recent stimulus bill would funnel billions to the health care supply chain quickly. Recent executive orders indicate the feds aim to focus on health care supply chain long term.
Delaying second doses would change the distribution pattern for vaccines and reshape the supply chain. Also, vaccine manufacturers say supply is about to dramatically increase.
Matt Waller, dean of the Sam M. Walton College of Business at the University of Arkansas, and Kathy Wengel, executive vice president and chief global supply chain officer for Johnson & Johnson, discuss key trends that have emerged in the global supply chain during the COVID-19 pandemic as suppliers, manufacturers and distributors collaborated to ensure critical supplies were deployed all over the world.
Day Three of Global Supply Chain Week will cover topics related to food and CPG supply chains. Tyson Foods Chief Sustainability Officer John Tyson is set to start the day off with global sustainability in mind.
In today’s edition of The Daily Dash, global logistics operator DB Schenker eyes the U.S. market. Plus, U.S. Xpress’ CEO sees big things coming for its Variant division, and flatbed operator Daseke reports earnings and issues a mixed outlook for 2021.
